Neurobiology and Neurochemistry of Reward and Addictive Behaviours Flashcards

1
Q

What is Addiction / substance dependence?

A
  • A persistent disorder of brain function in which compulsive drug use occurs despite serious negative consequences for the afflicted individual.
  • Both physical and psychological.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Addiction / substance dependence :

  • A persistent disorder of brain function in which compulsive drug use occurs despite serious negative consequences for the afflicted individual.
  • Both physical and psychological.
A
  • A persistent disorder of brain function in which compulsive drug use occurs despite serious negative consequences for the afflicted individual.
  • Both physical and psychological.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Withdrawal symptoms

  • Negative … and … features that occur when the drug is not taken.
  • Different for each drug of abuse, but generally … to positive experience induced by the drug.
A
  • Negative physiological and emotional features that occur when the drug is not taken.
  • Different for each drug of abuse, but generally opposite to positive experience induced by the drug.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are Withdrawal symptoms?

A
  • Negative physiological and emotional features that occur when the drug is not taken.
  • Different for each drug of abuse, but generally opposite to positive experience induced by the drug.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is Tolerance (drugs)?

A
  • Diminished response to the effects of a given amount of drug following repeated exposures to the drug.
  • This implies that increasingly larger doses of the drug are required to induce the same behavioural effect.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Tolerance (drugs)

  • … response to the effects of a given amount of drug following repeated … to the drug.
  • This implies that … larger doses of the drug are required to induce the same … effect.
A
  • Diminished response to the effects of a given amount of drug following repeated exposures to the drug.
  • This implies that increasingly larger doses of the drug are required to induce the same behavioural effect.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Where do drugs act in the brain?

A
  • Drugs hijack the natural reward system
  • Mesolimbic system and Mesocortical system - the Mesocorticolimbic pathway (reward & reinforcement, provides stimulus salience)
  • Addiction also involves the:
    • Pre Frontal Cortex (impulsiveness, decision making, self monitoring)
    • Amygdala
    • Hippocampus
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Where do drugs act in the brain?

  • Drugs hijack the natural reward system
  • … system and … system - the … pathway (reward & reinforcement, provides stimulus salience)
  • Addiction also involves the:
    • Pre … … (impulsiveness, decision making, self monitoring)
    • A…
    • H…
A
  • Drugs hijack the natural reward system
  • Mesolimbic system and Mesocortical system - the Mesocorticolimbic pathway (reward & reinforcement, provides stimulus salience)
  • Addiction also involves the:
    • Pre Frontal Cortex (impulsiveness, decision making, self monitoring)
    • Amygdala
    • Hippocampus
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Anticipation of reward recruits NAcc (stands for the … …)

A

Anticipation of reward recruits NAcc (nucleus accumbens)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Anticipation of rewards rather than the reward itself that causes the recruitment of the … …

A

Anticipation of rewards rather than the reward itself that causes the recruitment of the Nucleus Accumbens

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is the primary activating neurotransmitter for the reward pathway?

A

Dopamine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

DA as an “error” or “learning” signal

  • Monkey hooked up with electrodes within the brain, reading activity. Completes task of hitting button in response to stimulus on the screen, electrical activity measured at tip of electrode.
  • If just given a reward with no stimulus i.e. an unexpected award that cannot be predicted then when is there is a spike in activity?
  • However, if presented with stimulus prior to the reward then we note a spike in activity when?
    • Note that this spike is … intense than that of the one when he actually receives the reward
  • If reward does not come (monkey makes an error on test) then do we still get the anticipation spike?
A
  • Monkey hooked up with electrodes within the brain, reading activity. Completes task of hitting button in response to stimulus on the screen, electrical activity measured at tip of electrode.
  • If just given a reward with no stimulus i.e. an unexpected award that cannot be predicted then there is a spike in activity after the reward
  • However, if presented with stimulus prior to the reward then we note a spike in activity before the reward i.e. reward predicted and the response is in anticipation of the reward
    • Note that this spike is more intense than that of the one when he actually receives the reward i.e. the anticipation is more ‘pleasurable’ than the reward itself
  • If reward does not come (monkey makes an error on test) then still get the anticipation spike but see a fall in dopaminergic effect at time that reward would have come
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

When a reward is unexpected then we see activity in the … …

  • (However, once it is learnt, i.e. predictable, this response disappears from the … and the response is seen in the … … – indicating that learning has taken place)
A
  • When a reward is unexpected then we see activity in the Nucleus Accumbensthink of this as a response that ‘tells’ our brain that there is something we should be learning
  • (However, once it is learnt, i.e. predictable, this response disappears from the NAcc and the response is seen in the temporal lobes – indicating that learning has taken place)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Functions of the Reinforcement System

  • Detect reinforcing stimulus
    • Recognise something … has just happened
    • Time to …
  • Strengthen … connections
    • Between neurons that detect the … and the neurons that produce the … response
    • Long term …
A
  • Detect reinforcing stimulus
    • Recognise something good has just happened
    • Time to learn
  • Strengthen neural connections
    • Between neurons that detect the stimulus and the neurons that produce the instrumental response
    • Long term potentiation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

The mesocorticolimbic dopamine system

  • Dopamine neurons project from the … to the … and PFC
  • Pathway for r… and r..
  • … … activate this system
A
  • Dopamine neurons project from the VTA to the Nacc and PFC
  • Pathway for reward and reinforcement
  • Addictive drugs activate this system
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Mesocorticolimbic dopamine system

  • Behaviours activating system are …
    • More likely to be …
  • … drugs causes more powerful and reliable activation than … rewards
    • they hijack the system
  • … of … in this region
    • attenuates most measurable reinforcing and rewarding effects of addictive drugs
A
  • Behaviours activating system are reinforced
    • More likely to be repeated
  • Addictive drugs causes more powerful and reliable activation than natural rewards
    • they hijack the system
  • Blockade of DA in this region
    • attenuates most measurable reinforcing and rewarding effects of addictive drugs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Common drug effects on DA system

  • All drugs have effect on DAergic system
  • Though through different mechanisms – e.g:
    • … - Direct action on Daergic neurons in NAcc
    • … - Indirectly – inhibit GABAergic interneurons in VTA = disinhibition of VTA DA neurons
    • … - Disinhibition of VTA DA neurons
    • … - Increases Nacc DA directly and indirectly, stimulates nicotinic cholinergic receptors on mesocortiolimbic DA neurons
A
  • All drugs have effect on DAergic system
  • Though through different mechanisms – e.g:
    • Psychostimulants - Direct action on Daergic neurons in NAcc
    • Opiates - Indirectly – inhibit GABAergic interneurons in VTA = disinhibition of VTA DA neurons
    • Alcohol - Disinhibition of VTA DA neurons
    • Nicotine - Increases Nacc DA directly and indirectly, stimulates nicotinic cholinergic receptors on mesocortiolimbic DA neurons
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Common drug effects on DA system

  • All drugs have effect on DAergic system
  • Though through different mechanisms – e.g:
    • Psychostimulants - … action on Daergic neurons in NAcc
    • Opiates - Indirectly – inhibit … interneurons in VTA = disinhibition of VTA DA neurons
    • Alcohol - … of VTA DA neurons
    • Nicotine - … Nacc DA directly and indirectly, stimulates nicotinic cholinergic receptors on mesocortiolimbic DA neurons
A
  • All drugs have effect on DAergic system
  • Though through different mechanisms – e.g:
    • Psychostimulants - Direct action on Daergic neurons in NAcc
    • Opiates - Indirectly – inhibit GABAergic interneurons in VTA = disinhibition of VTA DA neurons
    • Alcohol - Disinhibition of VTA DA neurons
    • Nicotine - Increases Nacc DA directly and indirectly, stimulates nicotinic cholinergic receptors on mesocortiolimbic DA neurons
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

This dopaminergic response is a normal reaction

  • The … system will be activated in response to many stimuli – central to …
A

The mesolimbic system will be activated in response to many stimuli – central to motivation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Drugs increase DA release in the NAcc -> Drug taking is reinforced -> But how do we get addicted?

  • HOMEOSTATIC CHANGES – NEURONAL ADAPTATIONS lead to …:
    • diminishing effect of drug after repeated administration
    • need more drug to get the same effect
  • …:
    • physical or emotional - adaptive state
    • homeostatic response to repeated drug administration
    • unmasked by withdrawal
  • ASSOCIATIVE LEARNING PROCESSES – SYNAPTIC PLASTICITY lead to
  • …:
    • repeated administration elicits escalating effects
    • effect of psychostimulants (used in animal models)
  • …:
    • compulsive taking
    • craving and relapse
    • persistent for many years
A
  • HOMEOSTATIC CHANGES – NEURONAL ADAPTATIONS lead to Tolerance:
    • diminishing effect of drug after repeated administration
    • need more drug to get the same effect
  • Dependence:
    • physical or emotional - adaptive state
    • homeostatic response to repeated drug administration
    • unmasked by withdrawal
  • ASSOCIATIVE LEARNING PROCESSES – SYNAPTIC PLASTICITY lead to
  • Sensitization:
    • repeated administration elicits escalating effects
    • effect of psychostimulants (used in animal models)
  • Addiction:
    • compulsive taking
    • craving and relapse
    • persistent for many years
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Drugs increase DA release in the NAcc -> Drug taking is reinforced -> But how do we get addicted?

  • … CHANGES – … ADAPTATIONS lead to Tolerance:
    • diminishing effect of drug after repeated administration
    • need more drug to get the same effect
  • Dependence:
    • physical or emotional - adaptive state
    • homeostatic response to repeated drug administration
    • unmasked by withdrawal
  • … … PROCESSES – SYNAPTIC … lead to
  • Sensitization:
    • repeated administration elicits escalating effects
    • effect of psychostimulants (used in animal models)
  • Addiction:
    • compulsive taking
    • craving and relapse
    • persistent for many years
A
  • HOMEOSTATIC CHANGES – NEURONAL ADAPTATIONS lead to Tolerance:
    • diminishing effect of drug after repeated administration
    • need more drug to get the same effect
  • Dependence:
    • physical or emotional - adaptive state
    • homeostatic response to repeated drug administration
    • unmasked by withdrawal
  • ASSOCIATIVE LEARNING PROCESSES – SYNAPTIC PLASTICITY lead to
  • Sensitization:
    • repeated administration elicits escalating effects
    • effect of psychostimulants (used in animal models)
  • Addiction:
    • compulsive taking
    • craving and relapse
    • persistent for many years
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Cocaine and amphetamine – DA agonists

  • Potentiate monoaminergic transmission by inhibition of dopamine (DA), serotonin (5-HT) and norepinephrine (NE) reuptake transporters
    • … blocks and inhibits transporter to prolong pool of extracellular DA
    • … reverses transporter to increase extracellular DA levels
  • Action at dopamine transporter (DAT) most directly related to … effects
  • Feelings of … etc. through activation of this pathway or actions at transporters located elsewhere
  • Cocaine and amphetamine … extracellular DA in NAcc
A
  • Potentiate monoaminergic transmission by inhibition of dopamine (DA), serotonin (5-HT) and norepinephrine (NE) reuptake transporters
    • Cocaine blocks and inhibits transporter to prolong pool of extracellular DA
    • Amphetamine reverses transporter to increase extracellular DA levels
  • Action at dopamine transporter (DAT) most directly related to reinforcing effects
  • Feelings of euphoria etc. through activation of this pathway or actions at transporters located elsewhere
  • Cocaine and amphetamine increases extracellular DA in NAcc
23
Q

Cocaine and amphetamine – DA agonists

  • Potentiate monoaminergic transmission by inhibition of dopamine (DA), serotonin (5-HT) and norepinephrine (NE) reuptake transporters
    • Cocaine blocks and inhibits transporter to prolong pool of extracellular DA
    • Amphetamine reverses transporter to increase extracellular DA levels
  • Action at … … (DAT) most directly related to reinforcing effects
  • Feelings of euphoria etc. through activation of this pathway or actions at transporters located elsewhere
  • Cocaine and amphetamine increases extracellular DA in NAcc
A
  • Potentiate monoaminergic transmission by inhibition of dopamine (DA), serotonin (5-HT) and norepinephrine (NE) reuptake transporters
    • Cocaine blocks and inhibits transporter to prolong pool of extracellular DA
    • Amphetamine reverses transporter to increase extracellular DA levels
  • Action at dopamine transporter (DAT) most directly related to reinforcing effects
  • Feelings of euphoria etc. through activation of this pathway or actions at transporters located elsewhere
  • Cocaine and amphetamine increases extracellular DA in NAcc
24
Q

Cocaine and amphetamine have different actions - Though similar net effect
-> … synaptic DA

A

Cocaine and amphetamine have different actions - Though similar net effect
-> Increased synaptic DA

25
Q

Binding sites of cocaine following acute administration

A
  • These studies show a similarity between the time-course of cocaine receptor (dopamine transporter) occupancy and the timecourse of the psychological effects of cocaine in humans, suggesting a direct relationship. Also, prolonged use or high doses of cocaine causes paranoia and psychosis - symptoms often associated with schizophrenia, a syndrome thought to involve the dopaminergic limbic pathway.
26
Q

Cocaine and amphetamine

  • Effects:
    • … behaviour (Evidence DA involvement in the positive symptoms of schizophrenia)
    • Adverse …-… effects on the brain, e.g. DA transporters / terminals
    • Cellular and molecular changes that promote …, e.g. increased activity of VTA tyrosine hydroxylase, CREB, GluR1 (AMPA)
    • Hypo…
A
  • Effects:
    • Psychotic behaviour (Evidence DA involvement in the positive symptoms of schizophrenia)
    • Adverse long-term effects on the brain, e.g. DA transporters / terminals
    • Cellular and molecular changes that promote dysregulation, e.g. increased activity of VTA tyrosine hydroxylase, CREB, GluR1 (AMPA)
    • Hypofrontality
27
Q

Increased excitatory strength - 24 hours after injection (addictive drugs)

  • All drugs of abuse - significant … in the AMPA/NMDA ratio
  • An … in basal excitatory synaptic strength.
  • Neuronal basis of many forms of …
    • One injection – changes persist for … days
    • Animal receives injections for … weeks – changes persist in VTA
A
  • All drugs of abuse - significant increase in the AMPA/NMDA ratio
  • An increase in basal excitatory synaptic strength.
  • Neuronal basis of many forms of learning
    • One injection – changes persist for 5 days
    • Animal receives injections for 2 weeks – changes persist in VTA
28
Q

What is the VTA?

A
  • The VTA is a midbrain structure that disperses both dopaminergic and non-dopaminergic projections throughout the mesocorticolimbic system
  • The VTA is comprised of a group of neurons located around the midline of the midbrain floor and contains mainly neurons that produce DA. The VTA–DA neurons participate in drug addiction, behavioral disorders, cognition, motivation, and locomotor activity. The activity of dopaminergic neurons in the VTA is linked to reward prediction. Most drugs of abuse modulate this system.
29
Q
  • The VTA is a midbrain structure that disperses both dopaminergic and non-dopaminergic projections throughout the … system
  • The VTA is comprised of a group of neurons located around the midline of the midbrain floor and contains mainly neurons that produce … The VTA–DA neurons participate in drug …, … disorders, cognition, M…, and locomotor activity. The activity of dopaminergic neurons in the VTA is linked to … prediction. Most drugs of … modulate this system.
A
  • The VTA is a midbrain structure that disperses both dopaminergic and non-dopaminergic projections throughout the mesocorticolimbic system
  • The VTA is comprised of a group of neurons located around the midline of the midbrain floor and contains mainly neurons that produce DA. The VTA–DA neurons participate in drug addiction, behavioral disorders, cognition, motivation, and locomotor activity. The activity of dopaminergic neurons in the VTA is linked to reward prediction. Most drugs of abuse modulate this system.
30
Q

more or less D2 receptors in addiction?

A
  • Fewer - D2 receptors cause inhibition and suppress behaviour
  • Decreased dopamine (D2) receptors in cocaine addict
  • The dopamine system central to conditioning and motivation
  • Changes above likely responsible for reduced sensitivity to natural rewards that develops with addiction.
31
Q

Fewer D2 receptors in addiction - why?

A
  • D2 receptors cause inhibition and suppress behaviour
  • Decreased dopamine (D2) receptors in cocaine addict
  • The dopamine system central to conditioning and motivation
  • Changes above likely responsible for reduced sensitivity to natural rewards that develops with addiction.
32
Q

Emotional Dependence (e.g. psychomotor stimulants) - (dysphoria, anhedonia, anxiety on withdrawal)

  • Compensatory changes in VTA / NAcc to lower DA transmission:
    • Increased activity at … receptors (Gs coupled) in NAcc
    • Adenylyl cyclase - cAMP - PKA - downstream events
    • increased dynorphin (DYN) synthesis (endogenous opioid)
  • dynorphin released in VTA acts at K … receptor
    • Inhibits VTA neuron firing and NAcc DA release
    • therefore … DA release in NAcc
  • In absence of drugs boosting DA function, not enough DA for natural rewarding stimuli - anhedonia, dysphoria etc.
A
  • Compensatory changes in VTA / NAcc to lower DA transmission:
    • Increased activity at D1 receptors (Gs coupled) in NAcc
    • Adenylyl cyclase - cAMP - PKA - downstream events
    • increased dynorphin (DYN) synthesis (endogenous opioid)
  • dynorphin released in VTA acts at K opioid receptor
    • Inhibits VTA neuron firing and NAcc DA release
    • therefore Less DA release in NAcc
  • In absence of drugs boosting DA function, not enough DA for natural rewarding stimuli - anhedonia, dysphoria etc.
33
Q

Associative learning - what makes drugs addictive?

  • Coincident firing between sensory pathways and the mesocorticolimbic pathway will induce LTP and strengthen synaptic connections
  • Reminder – LTP = … … …
    • A persistent strengthening of synapses based on recent patterns of activity
    • Used to explain …
  • Potential sites for LTP:
    • … synapses on reciprocal connections between NAcc, VTA, cortex, hippocampus and amygdala
  • Thus sensory information, people, places, emotions etc. present at the time when drug induced DA release occurs will become … with taking the drug
A
  • Coincident firing between sensory pathways and the mesocorticolimbic pathway will induce LTP and strengthen synaptic connections
  • Reminder – LTP = Long Term Potentiation
    • A persistent strengthening of synapses based on recent patterns of activity
    • Used to explain memory
  • Potential sites for LTP:
    • Glutamatergic synapses on reciprocal connections between NAcc, VTA, cortex, hippocampus and amygdala
  • Thus sensory information, people, places, emotions etc. present at the time when drug induced DA release occurs will become associated with taking the drug
34
Q

Associative learning - what makes drugs addictive?

  • Coincident firing between sensory pathways and the … pathway will induce LTP and strengthen synaptic connections
  • Reminder – LTP = Long Term Potentiation
    • A persistent … of … based on recent patterns of …
    • Used to explain memory
  • Potential sites for LTP:
    • Glutamatergic synapses on reciprocal connections between NAcc, VTA, cortex, hippocampus and amygdala
  • Thus sensory information, people, places, emotions etc. present at the time when … induced … release occurs will become associated with…
A
  • Coincident firing between sensory pathways and the mesocorticolimbic pathway will induce LTP and strengthen synaptic connections
  • Reminder – LTP = Long Term Potentiation
    • A persistent strengthening of synapses based on recent patterns of activity
    • Used to explain memory
  • Potential sites for LTP:
    • Glutamatergic synapses on reciprocal connections between NAcc, VTA, cortex, hippocampus and amygdala
  • Thus sensory information, people, places, emotions etc. present at the time when drug induced DA release occurs will become associated with taking the drug
35
Q

Associative learning - sensory information, people, places, emotions etc. present at the time when drug induced DA release occurs will become associated with …

A

sensory information, people, places, emotions etc. present at the time when drug induced DA release occurs will become associated with taking the drug

36
Q

Dopamine enhances .. … …

A

Dopamine enhances Long Term Potentiation

37
Q

Dopamine enhances Long Term Potentiation

  • Dopamine at D1 receptor (Gs coupled)
  • adenylyl cyclase - cAMP - PKA
    • modifies glutamatergic transmission allowing …
    • CREB mediated gene transcription and new protein synthesis (steps in late phase LTP)
    • synaptic … - increased spines and dendritic branches
    • long term molecular and cellular changes remain months after …
    • … in these pathways may trigger relapse years later
A
  • Dopamine at D1 receptor (Gs coupled)
  • adenylyl cyclase - cAMP - PKA
    • modifies glutamatergic transmission allowing LTP
    • CREB mediated gene transcription and new protein synthesis (steps in late phase LTP)
    • synaptic remodelling - increased spines and dendritic branches
    • long term molecular and cellular changes remain months after abstinence
    • memories in these pathways may trigger relapse years later
38
Q

Dopamine enhances Long Term Potentiation

  • Dopamine at … receptor (Gs coupled)
  • … cyclase - cAMP - …
    • modifies glutamatergic transmission allowing LTP
    • CREB mediated gene transcription and new protein synthesis (steps in late phase LTP)
    • synaptic remodelling - increased spines and dendritic branches
    • long term … and … changes remain months after abstinence
    • memories in these pathways may trigger … years later
A
  • Dopamine at D1 receptor (Gs coupled)
  • adenylyl cyclase - cAMP - PKA
    • modifies glutamatergic transmission allowing LTP
    • CREB mediated gene transcription and new protein synthesis (steps in late phase LTP)
    • synaptic remodelling - increased spines and dendritic branches
    • long term molecular and cellular changes remain months after abstinence
    • memories in these pathways may trigger relapse years later
39
Q

Opiates (e.g. morphine and heroin)

  • Action:
    • endogenous opioid receptors (Gi coupled)
      • … - decrease adenylyl cyclase activity - lead to open K+ channels, close Ca2+ channels
  • Different receptor subtypes
    • on different cells in different brain regions (m, k, d)
  • Most of morphine’s analgesic and rewarding properties are through actions at m (mu) receptors
  • … and … by:
    • a) … of DA neurons in VTA (DA neurons fire tonically but are inhibited by GABA interneurons - m receptor activation on GABA neurons inhibits them from firing - relieving inhibition on DA neurons)
    • b) Action at opiate receptors in the NAcc - independent of DA release (m or d)
A
  • Action:
    • endogenous opioid receptors (Gi coupled)
      • Inhibitory - decrease adenylyl cyclase activity - lead to open K+ channels, close Ca2+ channels
  • Different receptor subtypes
    • on different cells in different brain regions (m, k, d)
  • Most of morphine’s analgesic and rewarding properties are through actions at m (mu) receptors
  • Reward and reinforcement by:
    • a) Disinhibition of DA neurons in VTA (DA neurons fire tonically but are inhibited by GABA interneurons - m receptor activation on GABA neurons inhibits them from firing - relieving inhibition on DA neurons)
    • b) Action at opiate receptors in the NAcc - independent of DA release (m or d)
40
Q

Opiates (e.g. morphine and heroin)

  • Action:
    • endogenous opioid receptors (Gi coupled)
      • Inhibitory - decrease … … activity - lead to … K+ channels, … Ca2+ channels
  • Different receptor subtypes
    • on different cells in different brain regions (m, k, d)
  • Most of morphine’s analgesic and rewarding properties are through actions at m (mu) receptors
  • Reward and reinforcement by:
    • a) Disinhibition of … neurons in VTA (DA neurons fire tonically but are inhibited by GABA interneurons - m receptor activation on GABA neurons inhibits them from firing - relieving inhibition on DA neurons)
    • b) Action at opiate receptors in the … - independent of DA release (m or d)
A
  • Action:
    • endogenous opioid receptors (Gi coupled)
      • Inhibitory - decrease adenylyl cyclase activity - lead to open K+ channels, close Ca2+ channels
  • Different receptor subtypes
    • on different cells in different brain regions (m, k, d)
  • Most of morphine’s analgesic and rewarding properties are through actions at m (mu) receptors
  • Reward and reinforcement by:
    • a) Disinhibition of DA neurons in VTA (DA neurons fire tonically but are inhibited by GABA interneurons - m receptor activation on GABA neurons inhibits them from firing - relieving inhibition on DA neurons)
    • b) Action at opiate receptors in the NAcc - independent of DA release (m or d)
41
Q

2 opiate examples

A

heroin, morphine

42
Q

Alcohol (EtOH)

  • 1)… agonist (inhibitory)
  • 2)… antagonist (blocks excitation)
    • Large doses inhibit functioning of most … … channels
  • EtOH leads to … DA release in NAcc
    • NMDA antagonism of cortical inputs to VTA disinhibits VTA DA neurons - resulting in … DA release in NAcc.
  • Ethanol rewarding effects blocked by DA receptor … in NAcc
  • Opiate system involvement
    • N.. (an opiate antagonist)
    • reduces EtOH self administration in animals
      • used as a treatment to reduce EtOH consumption, relapse and craving in alcoholics
A
  • 1)GABAA agonist (inhibitory)
  • 2)NMDA antagonist (blocks excitation)
    • Large doses inhibit functioning of most voltage gated channels
  • EtOH leads to increased DA release in NAcc
    • NMDA antagonism of cortical inputs to VTA disinhibits VTA DA neurons - resulting in increased DA release in NAcc.
  • Ethanol rewarding effects blocked by DA receptor antagonists in NAcc
  • Opiate system involvement
    • Naltrexone (an opiate antagonist)
    • reduces EtOH self administration in animals
      • used as a treatment to reduce EtOH consumption, relapse and craving in alcoholics
43
Q

Alcohol (EtOH)

  • 1)GABAA agonist (…)
  • 2)NMDA antagonist (blocks …)
    • … doses inhibit functioning of most voltage gated channels
  • EtOH leads to increased DA release in NAcc
    • NMDA antagonism of cortical inputs to VTA disinhibits VTA DA neurons - resulting in increased DA release in NAcc.
  • Ethanol rewarding effects blocked by DA receptor antagonists in NAcc
  • Opiate system involvement
    • Naltrexone (an opiate …)
    • reduces EtOH … … in animals
      • used as a treatment to reduce EtOH …, … and … in alcoholics
A
  • 1)GABAA agonist (inhibitory)
  • 2)NMDA antagonist (blocks excitation)
    • Large doses inhibit functioning of most voltage gated channels
  • EtOH leads to increased DA release in NAcc
    • NMDA antagonism of cortical inputs to VTA disinhibits VTA DA neurons - resulting in increased DA release in NAcc.
  • Ethanol rewarding effects blocked by DA receptor antagonists in NAcc
  • Opiate system involvement
    • Naltrexone (an opiate antagonist)
    • reduces EtOH self administration in animals
      • used as a treatment to reduce EtOH consumption, relapse and craving in alcoholics
44
Q

What is naltrexone?

A
  • ​Naltrexone is an opioid receptor antagonist. It blocks the feeling of pleasure when the opiates are taken.
  • reduces EtOH self administration in animals
  • used as a treatment to reduce EtOH consumption, relapse and craving in alcoholics
45
Q

What does naltrexone do?

A
  • ​Naltrexone is an opioid receptor antagonist. It blocks the feeling of pleasure when the opiates are taken.
  • reduces EtOH self administration in animals
  • used as a treatment to reduce EtOH consumption, relapse and craving in alcoholics
46
Q

Naltrexone is used as a treatment for who?

A

Alcoholics - used as a treatment to reduce EtOH consumption, relapse and craving in alcoholics

also used in smoking cessation

47
Q

Overview - firing in VTA and nucleus accumbens

A
48
Q

Nicotine

  • Acts at nicotinic acetylcholine receptors (nAChRs)
    • … … ion channels located pre or post-synaptically (present throughout …, excitatory or modulatory)
    • … receptors - influx of Ca2+ - transmitter release
  • Nicotine treatment … DA release in the NAcc
    • ….. of DA likely due to:
      • a) activation of receptors on cell body in the VTA (increasing cell firing)
      • b) facilitation of DA release by pre-synaptic receptors in NAcc
  • Opiate system involvement
    • Both opiate and DA antagonists can … nicotine induced behaviours and self administration
    • (Naltrexone as a drug to aid smoking cessation and associated weight gain, encouraging preliminary results)
A
  • Acts at nicotinic acetylcholine receptors (nAChRs)
    • Ligand gated ion channels located pre or post-synaptically (present throughout brain, excitatory or modulatory)
    • Presynaptic receptors - influx of Ca2+ - transmitter release
  • Nicotine treatment increases DA release in the NAcc
    • Release of DA likely due to:
      • a) activation of receptors on cell body in the VTA (increasing cell firing)
      • b) facilitation of DA release by pre-synaptic receptors in NAcc
  • Opiate system involvement
    • Both opiate and DA antagonists can block nicotine induced behaviours and self administration
    • (Naltrexone as a drug to aid smoking cessation and associated weight gain, encouraging preliminary results)
49
Q

Nicotine

  • Acts at nicotinic acetylcholine receptors (nAChRs)
    • Ligand gated ion channels located pre or post-synaptically (present throughout brain, excitatory or …)
    • Presynaptic receptors - influx of …+ - transmitter release
  • Nicotine treatment increases DA release in the NAcc
    • Release of DA likely due to:
      • a) activation of receptors on cell body in the VTA (increasing cell …)
      • b) facilitation of DA release by …-synaptic receptors in NAcc
  • Opiate system involvement
    • Both opiate and DA antagonists can block nicotine induced behaviours and self administration
    • (… as a drug to aid … cessation and associated weight gain, encouraging preliminary results)
A
  • Acts at nicotinic acetylcholine receptors (nAChRs)
    • Ligand gated ion channels located pre or post-synaptically (present throughout brain, excitatory or modulatory)
    • Presynaptic receptors - influx of Ca2+ - transmitter release
  • Nicotine treatment increases DA release in the NAcc
    • Release of DA likely due to:
      • a) activation of receptors on cell body in the VTA (increasing cell firing)
      • b) facilitation of DA release by pre-synaptic receptors in NAcc
  • Opiate system involvement
    • Both opiate and DA antagonists can block nicotine induced behaviours and self administration
    • (Naltrexone as a drug to aid smoking cessation and associated weight gain, encouraging preliminary results)
50
Q

Physical dependence to opiates

  • Opiate receptors present in mesocorticolimbic circuits but also other systems e.g. Spinal cord and pain pathways
  • Locus coeruleus (LC) - Noradrenergic nuclei controlling attention, arousal and vigilance (responsible for eliciting “fight or flight” autonomic responses)
  • Chronic activation of opiate receptors leads to homeostatic mechanism that compensates for the functional changes leading to … and physical …
  • … morphine - acutely inhibits firing of LC neurons
  • … treatment - LC neurons return to their normal firing rates
  • … - dramatic increase in LC firing
      • correlates with the physical withdrawal symptoms
      • trigger overactivation of the autonomic nervous system
      • can be blocked by clonidine (a2 adrenergic receptor agonist)
  • Intracellular mechanism in LC neurons leads to the … (same events will result in tolerance to analgesic effects)
A
  • Opiate receptors present in mesocorticolimbic circuits but also other systems e.g. Spinal cord and pain pathways
  • Locus coeruleus (LC) - Noradrenergic nuclei controlling attention, arousal and vigilance (responsible for eliciting “fight or flight” autonomic responses)
  • Chronic activation of opiate receptors leads to homeostatic mechanism that compensates for the functional changes leading to tolerance and physical dependence
  • Acute morphine - acutely inhibits firing of LC neurons
  • Chronic treatment - LC neurons return to their normal firing rates
  • Withdrawal - dramatic increase in LC firing
      • correlates with the physical withdrawal symptoms
      • trigger overactivation of the autonomic nervous system
      • can be blocked by clonidine (a2 adrenergic receptor agonist)
  • Intracellular mechanism in LC neurons leads to the compensation (same events will result in tolerance to analgesic effects)
51
Q

Physical dependence to opiates

  • Opiate receptors present in mesocorticolimbic circuits but also other systems e.g. Spinal cord and pain pathways
  • Locus coeruleus (LC) - Noradrenergic nuclei controlling attention, arousal and vigilance (responsible for eliciting “… or …” autonomic responses)
  • Chronic activation of opiate receptors leads to homeostatic mechanism that compensates for the functional changes leading to tolerance and physical dependence
  • Acute morphine - acutely … firing of LC neurons
  • Chronic treatment - LC neurons return to their normal … …
  • Withdrawal - dramatic … in LC firing
      • correlates with the … withdrawal symptoms
      • trigger … of the autonomic nervous system
      • can be blocked by … (a2 adrenergic receptor agonist)
  • Intracellular mechanism in LC neurons leads to the compensation (same events will result in tolerance to analgesic effects)
A
  • Opiate receptors present in mesocorticolimbic circuits but also other systems e.g. Spinal cord and pain pathways
  • Locus coeruleus (LC) - Noradrenergic nuclei controlling attention, arousal and vigilance (responsible for eliciting “fight or flight” autonomic responses)
  • Chronic activation of opiate receptors leads to homeostatic mechanism that compensates for the functional changes leading to tolerance and physical dependence
  • Acute morphine - acutely inhibits firing of LC neurons
  • Chronic treatment - LC neurons return to their normal firing rates
  • Withdrawal - dramatic increase in LC firing
      • correlates with the physical withdrawal symptoms
      • trigger overactivation of the autonomic nervous system
      • can be blocked by clonidine (a2 adrenergic receptor agonist)
  • Intracellular mechanism in LC neurons leads to the compensation (same events will result in tolerance to analgesic effects)
52
Q

Physical dependence to opiates

A
53
Q

Physical dependence to alcohol

  • Acute effects of alcohol
    • … at GABAA receptor
    • … at NMDA receptor
    • Cells inhibited from …
  • Chronic alcohol
    • …regulation of GABAA receptors
    • …regulation of NMDA receptors
    • In presence of alcohol firing rates return to …
  • Withdrawal - in absence of alcohol balance shifts to …
  • physical symptoms: agitation, tremors, hypertension, seizures
A
  • Acute effects of alcohol
    • agonist at GABAA receptor
    • antagonist at NMDA receptor
    • Cells inhibited from firing
  • Chronic alcohol
    • Down regulation of GABAA receptors
    • Upregulation of NMDA receptors
    • In presence of alcohol firing rates return to normal
  • Withdrawal - in absence of alcohol balance shifts to excitation
  • physical symptoms: agitation, tremors, hypertension, seizures
54
Q

Physical dependence to alcohol

  • Acute effects of alcohol
    • agonist at … receptor
    • antagonist at … receptor
    • Cells inhibited from firing
  • Chronic alcohol
    • Down regulation of … receptors
    • Upregulation of … receptors
    • In presence of alcohol firing rates return to normal
  • Withdrawal - in absence of alcohol balance shifts to excitation
  • physical symptoms: a…, t.., h.., s…
A
  • Acute effects of alcohol
    • agonist at GABAA receptor
    • antagonist at NMDA receptor
    • Cells inhibited from firing
  • Chronic alcohol
    • Down regulation of GABAA receptors
    • Upregulation of NMDA receptors
    • In presence of alcohol firing rates return to normal
  • Withdrawal - in absence of alcohol balance shifts to excitation
  • physical symptoms: agitation, tremors, hypertension, seizures